Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Non-Current Deferred Tax Liability (2022 - 2023)

Mainz Biomed's Non-Current Deferred Tax Liability history spans 2 years, with the latest figure at $138889.0 for Q4 2023.

  • For Q4 2023, Non-Current Deferred Tax Liability fell 30.35% year-over-year to $138889.0; the TTM value through Dec 2023 reached $138889.0, down 30.35%, while the annual FY2023 figure was $138889.0, 30.35% down from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2023 was $138889.0 at Mainz Biomed, down from $199410.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $199410.0 in Q4 2022 and bottomed at $138889.0 in Q4 2023.